{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:39:07Z","timestamp":1778546347139,"version":"3.51.4"},"reference-count":54,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2017,1,26]],"date-time":"2017-01-26T00:00:00Z","timestamp":1485388800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1"},{"start":{"date-parts":[[2017,1,26]],"date-time":"2017-01-26T00:00:00Z","timestamp":1485388800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions"}],"funder":[{"name":"JSPS KAKENHI","award":["15H01288"],"award-info":[{"award-number":["15H01288"]}]},{"name":"JSPS KAKENHI","award":["26670122"],"award-info":[{"award-number":["26670122"]}]},{"name":"JSPS KAKENHI","award":["26293020"],"award-info":[{"award-number":["26293020"]}]},{"name":"JSPS KAKENHI","award":["16K15126"],"award-info":[{"award-number":["16K15126"]}]},{"name":"JSPS KAKENHI","award":["16K19183"],"award-info":[{"award-number":["16K19183"]}]},{"name":"JSPS KAKENHI","award":["16K08268"],"award-info":[{"award-number":["16K08268"]}]},{"name":"JSPS KAKENHI","award":["25460099"],"award-info":[{"award-number":["25460099"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["British Journal of Pharmacology"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1111\/bph.13692","type":"journal-article","created":{"date-parts":[[2016,12,17]],"date-time":"2016-12-17T17:33:01Z","timestamp":1481995981000},"page":"314-327","source":"Crossref","is-referenced-by-count":12,"title":["Anti-anhedonic effect of selective serotonin reuptake inhibitors with affinity for sigma-1 receptors in picrotoxin-treated mice"],"prefix":"10.1111","volume":"174","author":[{"given":"S","family":"Hasebe","sequence":"first","affiliation":[{"name":"Department of Pharmacology, Graduate School of Dentistry; Osaka University; Osaka Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y","family":"Ago","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences; Osaka University; Osaka Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y","family":"Watabe","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences; Osaka University; Osaka Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Oka","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences; Osaka University; Osaka Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N","family":"Hiramatsu","sequence":"additional","affiliation":[{"name":"Laboratory of Medicinal Pharmacology, Graduate School of Pharmaceutical Sciences; Osaka University; Osaka Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences; Osaka University; Osaka Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Umehara","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences; Osaka University; Osaka Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Hashimoto","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences; Osaka University; Osaka Japan"},{"name":"United Graduate School of Child Development, Osaka University, Kanazawa University, Hamamatsu University School of Medicine, Chiba University and University of Fukui; Osaka Japan"},{"name":"Division of Bioscience, Institute for Datability Science; Osaka University; Osaka Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6484-1122","authenticated-orcid":false,"given":"K","family":"Takuma","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Graduate School of Dentistry; Osaka University; Osaka Japan"},{"name":"United Graduate School of Child Development, Osaka University, Kanazawa University, Hamamatsu University School of Medicine, Chiba University and University of Fukui; Osaka Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Matsuda","sequence":"additional","affiliation":[{"name":"Laboratory of Medicinal Pharmacology, Graduate School of Pharmaceutical Sciences; Osaka University; Osaka Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2017,1,26]]},"reference":[{"key":"10.1111\/bph.13692-BIB0001|bph13692-cit-0002","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1038\/npp.2013.52","article-title":"Role of social encounter-induced activation of prefrontal serotonergic systems in the abnormal behaviors of isolation-reared mice","volume":"38","author":"Ago","year":"2013a","journal-title":"Neuropsychopharmacology"},{"key":"10.1111\/bph.13692-BIB0002|bph13692-cit-0003","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ejphar.2005.08.011","article-title":"Antidepressant-like effect of coadministration of sulpiride and fluvoxamine in mice","volume":"520","author":"Ago","year":"2005b","journal-title":"Eur J Pharmacol"},{"key":"10.1111\/bph.13692-BIB0003|bph13692-cit-0004","doi-asserted-by":"crossref","first-page":"3125","DOI":"10.1007\/s00213-016-4353-3","article-title":"Involvement of GABAA receptors in 5-HT1A and \u03c31 receptor synergism on prefrontal dopaminergic transmission under circulating neurosteroid deficiency","volume":"233","author":"Ago","year":"2016","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1111\/bph.13692-BIB0004|bph13692-cit-0005","doi-asserted-by":"crossref","first-page":"pyv062","DOI":"10.1093\/ijnp\/pyv062","article-title":"The female encounter test, a novel method for evaluating reward-seeking behavior or motivation in mice","volume":"18","author":"Ago","year":"2015","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1111\/bph.13692-BIB0005|bph13692-cit-0006","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/sj.npp.1300567","article-title":"Sulpiride in combination with fluvoxamine increases in vivo dopamine release selectively in rat prefrontal cortex","volume":"30","author":"Ago","year":"2005a","journal-title":"Neuropsychopharmacology"},{"key":"10.1111\/bph.13692-BIB0006|bph13692-cit-0007","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.bbr.2014.04.047","article-title":"Social crowding in the night-time reduces an anxiety-like behavior and increases social interaction in adolescent mice","volume":"270","author":"Ago","year":"2014","journal-title":"Behav Brain Res"},{"key":"10.1111\/bph.13692-BIB0007|bph13692-cit-0008","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.neuropharm.2012.09.008","article-title":"Metabotropic glutamate 2\/3 receptor antagonists improve behavioral and prefrontal dopaminergic alterations in the chronic corticosterone-induced depression model in mice","volume":"65","author":"Ago","year":"2013b","journal-title":"Neuropharmacology"},{"key":"10.1111\/bph.13692-BIB0008|bph13692-cit-0009","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s00213-011-2293-5","article-title":"Fluvoxamine enhances prefrontal dopaminergic neurotransmission in adrenalectomised\/castrated mice via both 5-HT reuptake inhibition and \u03c31 receptor activation","volume":"217","author":"Ago","year":"2011","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1111\/bph.13692-BIB0009|bph13692-cit-0010","doi-asserted-by":"crossref","first-page":"5870","DOI":"10.1111\/bph.13350","article-title":"The Concise Guide to PHARMACOLOGY 2015\/16: Ligand-gated ion channels","volume":"172","author":"Alexander","year":"2015a","journal-title":"Br J Pharmacol"},{"key":"10.1111\/bph.13692-BIB0010|bph13692-cit-0011","doi-asserted-by":"crossref","first-page":"5744","DOI":"10.1111\/bph.13348","article-title":"The Concise Guide to PHARMACOLOGY 2015\/16: G protein-coupled receptors","volume":"172","author":"Alexander","year":"2015b","journal-title":"Br J Pharmacol"},{"key":"10.1111\/bph.13692-BIB0011|bph13692-cit-0012","doi-asserted-by":"crossref","first-page":"5734","DOI":"10.1111\/bph.13347","article-title":"The Concise Guide to PHARMACOLOGY 2015\/16: Overview","volume":"172","author":"Alexander","year":"2015c","journal-title":"Br J Pharmacol"},{"key":"10.1111\/bph.13692-BIB0012|bph13692-cit-0013","doi-asserted-by":"crossref","first-page":"6110","DOI":"10.1111\/bph.13355","article-title":"The Concise Guide to PHARMACOLOGY 2015\/16: Transporters","volume":"172","author":"Alexander","year":"2015d","journal-title":"Br J Pharmacol"},{"key":"10.1111\/bph.13692-BIB0013|bph13692-cit-0014","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/nrn1703","article-title":"Neurosteroids: endogenous regulators of the GABAA receptor","volume":"6","author":"Belelli","year":"2005","journal-title":"Nat Rev Neurosci"},{"key":"10.1111\/bph.13692-BIB0014|bph13692-cit-0015","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.neuron.2011.12.012","article-title":"Extrasynaptic GABAA receptors: their function in the CNS and implications for disease","volume":"73","author":"Brickley","year":"2012","journal-title":"Neuron"},{"key":"10.1111\/bph.13692-BIB0015|bph13692-cit-0016","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1111\/j.1368-5031.2005.00681.x","article-title":"Clinical effects of pharmacological variations in selective serotonin reuptake inhibitors: an overview","volume":"59","author":"Carrasco","year":"2005","journal-title":"Int J Clin Pract"},{"key":"10.1111\/bph.13692-BIB0016|bph13692-cit-0017","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00213-013-3276-5","article-title":"Neurosteroid interactions with synaptic and extrasynaptic GABAA receptors: regulation of subunit plasticity, phasic and tonic inhibition, and neuronal network excitability","volume":"230","author":"Carver","year":"2013","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1111\/bph.13692-BIB0017|bph13692-cit-0018","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1517\/13543784.16.9.1365","article-title":"Triple uptake inhibitors: therapeutic potential in depression and beyond","volume":"16","author":"Chen","year":"2007","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1111\/bph.13692-BIB0018|bph13692-cit-0019","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/12207","article-title":"Decreased GABAA-receptor clustering results in enhanced anxiety and a bias for threat cues","volume":"2","author":"Crestani","year":"1999","journal-title":"Nat Neurosci"},{"key":"10.1111\/bph.13692-BIB0019|bph13692-cit-0020","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.1111\/bph.12856","article-title":"Experimental design and analysis and their reporting: new guidance for publication in BJP","volume":"172","author":"Curtis","year":"2015","journal-title":"Br J Pharmacol"},{"key":"10.1111\/bph.13692-BIB0020|bph13692-cit-0021","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/s002130050148","article-title":"GABAergic influences on plus-maze behaviour in mice","volume":"128","author":"Dalvi","year":"1996","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1111\/bph.13692-BIB0021|bph13692-cit-0022","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0014-2999(00)00566-5","article-title":"The role of dopamine in the mechanism of action of antidepressant drugs","volume":"405","author":"D'Aquila","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1111\/bph.13692-BIB0022|bph13692-cit-0023","doi-asserted-by":"crossref","first-page":"3845","DOI":"10.1523\/JNEUROSCI.3609-06.2007","article-title":"GABAergic control of adult hippocampal neurogenesis in relation to behavior indicative of trait anxiety and depression states","volume":"27","author":"Earnheart","year":"2007","journal-title":"J Neurosci"},{"key":"10.1111\/bph.13692-BIB0023|bph13692-cit-0024","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3758\/BF03193146","article-title":"G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences","volume":"39","author":"Faul","year":"2007","journal-title":"Behav Res Methods"},{"key":"10.1111\/bph.13692-BIB0024|bph13692-cit-0025","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/0028-3908(84)90113-8","article-title":"Do the reductions in social interaction produced by picrotoxin and pentylenetetrazole indicate anxiogenic actions?","volume":"23","author":"File","year":"1984","journal-title":"Neuropharmacology"},{"key":"10.1111\/bph.13692-BIB0025|bph13692-cit-0026","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/nrn.2016.57","article-title":"Dysregulation of the dopamine system in the pathophysiology of schizophrenia and depression","volume":"17","author":"Grace","year":"2016","journal-title":"Nat Rev Neurosci"},{"key":"10.1111\/bph.13692-BIB0026|bph13692-cit-0027","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejphar.2013.04.003","article-title":"Involvement of the GABAergic system in the anxiolytic-like effect of the flavonoid ellagic acid in mice","volume":"710","author":"Girish","year":"2013","journal-title":"Eur J Pharmacol"},{"key":"10.1111\/bph.13692-BIB0027|bph13692-cit-0028","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/nrn3119","article-title":"Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications","volume":"12","author":"Goldstein","year":"2011","journal-title":"Nat Rev Neurosci"},{"key":"10.1111\/bph.13692-BIB0028|bph13692-cit-0029","doi-asserted-by":"publisher","DOI":"10.1002\/aur.1596","article-title":"Improvement by methylphenidate and atomoxetine of social interaction deficits and recognition memory impairment in a mouse model of valproic acid-induced autism","author":"Hara","year":"2016","journal-title":"Autism Res"},{"key":"10.1111\/bph.13692-BIB0029|bph13692-cit-0030","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1097\/FBP.0000000000000140","article-title":"Pharmacological profile of encounter-induced hyperactivity in isolation-reared mice","volume":"26","author":"Hasebe","year":"2015a","journal-title":"Behav Pharmacol"},{"key":"10.1111\/bph.13692-BIB0030|bph13692-cit-0031","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jphs.2015.01.001","article-title":"Role of the 5-HT1A autoreceptor in the enhancement of fluvoxamine-induced increases in prefrontal dopamine release by adrenalectomy\/castration in mice","volume":"127","author":"Hasebe","year":"2015b","journal-title":"J Pharmacol Sci"},{"key":"10.1111\/bph.13692-BIB0031|bph13692-cit-0032","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/sj.npp.1301047","article-title":"Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of fluvoxamine: role of sigma-1 receptors","volume":"32","author":"Hashimoto","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1111\/bph.13692-BIB0032|bph13692-cit-0033","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1517\/14728222.12.1.45","article-title":"An update on the development of drugs for neuropsychiatric disorders: focusing on the \u03c31 receptor ligand","volume":"12","author":"Hayashi","year":"2008","journal-title":"Expert Opin Ther Targets"},{"key":"10.1111\/bph.13692-BIB0033|bph13692-cit-0034","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.neuropharm.2013.06.026","article-title":"Synergistic effect of 5-HT1A and \u03c31 receptor activation on prefrontal dopaminergic transmission under circulating steroid deficiency","volume":"75","author":"Hiramatsu","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1111\/bph.13692-BIB0034|bph13692-cit-0035","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.biopsych.2007.04.001","article-title":"High occupancy of sigma-1 receptors in the human brain after single oral administration of fluvoxamine: a positron emission tomography study using [11C]SA4503","volume":"62","author":"Ishikawa","year":"2007","journal-title":"Biol Psychiatry"},{"key":"10.1111\/bph.13692-BIB0035|bph13692-cit-0036","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1038\/mp.2011.46","article-title":"New medications for drug addiction hiding in glutamatergic neuroplasticity","volume":"16","author":"Kalivas","year":"2011","journal-title":"Mol Psychiatry"},{"key":"10.1111\/bph.13692-BIB0036|bph13692-cit-0037","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1017\/S1461145711001714","article-title":"Autism-like behaviours with transient histone hyperacetylation in mice treated prenatally with valproic acid","volume":"16","author":"Kataoka","year":"2013","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1111\/bph.13692-BIB0037|bph13692-cit-0038","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.neuropharm.2010.10.009","article-title":"Increased binding of cortical and hippocampal group II metabotropic glutamate receptors in isolation-reared mice","volume":"60","author":"Kawasaki","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1111\/bph.13692-BIB0038|bph13692-cit-0039","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1111\/j.1476-5381.2010.00872.x","article-title":"Animal research: reporting in vivo experiments: the ARRIVE guidelines","volume":"160","author":"Kilkenny","year":"2010","journal-title":"Br J Pharmacol"},{"key":"10.1111\/bph.13692-BIB0039|bph13692-cit-0040","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1744-859X-9-23","article-title":"The opposite effects of fluvoxamine and sertraline in the treatment of psychotic major depression: a case report","volume":"9","author":"Kishimoto","year":"2010","journal-title":"Ann Gen Psychiatry"},{"key":"10.1111\/bph.13692-BIB0040|bph13692-cit-0041","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1471-4159.2010.06750.x","article-title":"Effects of acute and chronic administration of atomoxetine and methylphenidate on extracellular levels of noradrenaline, dopamine and serotonin in the prefrontal cortex and striatum of mice","volume":"114","author":"Koda","year":"2010","journal-title":"J Neurochem"},{"key":"10.1111\/bph.13692-BIB0041|bph13692-cit-0042","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1017\/S1461145708008547","article-title":"Further evidence for an antidepressant potential of the selective sigma1 agonist SA 4503: electrophysiological, morphological and behavioural studies","volume":"11","author":"Lucas","year":"2008","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1111\/bph.13692-BIB0042|bph13692-cit-0043","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/mp.2010.120","article-title":"The GABAergic deficit hypothesis of major depressive disorder","volume":"16","author":"Luscher","year":"2011","journal-title":"Mol Psychiatry"},{"key":"10.1111\/bph.13692-BIB0043|bph13692-cit-0044","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1038\/sj.npp.1301323","article-title":"Differential effects of \u03c31 receptor blockade on self-administration and conditioned reinstatement motivated by cocaine vs natural reward","volume":"32","author":"Martin-Fardon","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1111\/bph.13692-BIB0044|bph13692-cit-0045","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1111\/bph.12955","article-title":"Implementing guidelines on reporting research using animals (ARRIVE etc.): new requirements for publication in BJP","volume":"172","author":"McGrath","year":"2015","journal-title":"Br J Pharmacol"},{"key":"10.1111\/bph.13692-BIB0045|bph13692-cit-0046","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.bbr.2015.02.010","article-title":"Anxiolytic-like effects of restraint during the dark cycle in adolescent mice","volume":"284","author":"Ota","year":"2015","journal-title":"Behav Brain Res"},{"key":"10.1111\/bph.13692-BIB0046|bph13692-cit-0047","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.pbb.2008.03.015","article-title":"The value of genetic and pharmacological approaches to understanding the complexities of GABAA receptor subtype functions: the anxiolytic effects of benzodiazepines","volume":"90","author":"Reynolds","year":"2008","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1111\/bph.13692-BIB0047|bph13692-cit-0048","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/S0893-133X(01)00391-8","article-title":"Involvement of the \u03c31 receptor in cocaine-induced conditioned place preference: possible dependence on dopamine uptake blockade","volume":"26","author":"Romieu","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1111\/bph.13692-BIB0048|bph13692-cit-0049","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nrn3381","article-title":"The brain reward circuitry in mood disorders","volume":"14","author":"Russo","year":"2013","journal-title":"Nat Rev Neurosci"},{"key":"10.1111\/bph.13692-BIB0049|bph13692-cit-0050","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.biopsych.2010.04.024","article-title":"\u03b3-Aminobutyric acid-type A receptor deficits cause hypothalamic-pituitary-adrenal axis hyperactivity and antidepressant drug sensitivity reminiscent of melancholic forms of depression","volume":"68","author":"Shen","year":"2010","journal-title":"Biol Psychiatry"},{"key":"10.1111\/bph.13692-BIB0050|bph13692-cit-0051","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0306-3623(94)00148-G","article-title":"The modified light\/dark transition test in mice: evaluation of classic and putative anxiolytic and anxiogenic drugs","volume":"26","author":"Shimada","year":"1995","journal-title":"Gen Pharmacol"},{"issue":"Database Issue","key":"10.1111\/bph.13692-BIB0051|bph13692-cit-0052","doi-asserted-by":"crossref","first-page":"D1054","DOI":"10.1093\/nar\/gkv1037","article-title":"The IUPHAR\/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands","volume":"44","author":"Southan","year":"2016","journal-title":"Nucl Acids Res"},{"key":"10.1111\/bph.13692-BIB0052|bph13692-cit-0053","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/BF02244785","article-title":"Increase of extracellular dopamine in the prefrontal cortex: a trait of drugs with antidepressant potential?","volume":"115","author":"Tanda","year":"1994","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1111\/bph.13692-BIB0053|bph13692-cit-0054","doi-asserted-by":"crossref","first-page":"127130","DOI":"10.1007\/BF02246169","article-title":"Mianserin markedly and selectively increases extracellular dopamine in the prefrontal cortex as compared to the nucleus accumbens of the rat","volume":"123","author":"Tanda","year":"1996","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1111\/bph.13692-BIB0054|bph13692-cit-0055","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0091-3057(98)00093-8","article-title":"Beneficial effects of acute and repeated administrations of sigma receptor agonists on behavioral despair in mice exposed to tail suspension","volume":"61","author":"Ukai","year":"1998","journal-title":"Pharmacol Biochem Behav"}],"container-title":["British Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbph.13692","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/bph.13692\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T07:50:30Z","timestamp":1718956230000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/bph.13692"}},"subtitle":["Anti-anhedonic effects in picrotoxin mouse model"],"short-title":[],"issued":{"date-parts":[[2017,1,26]]},"references-count":54,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,2]]}},"URL":"https:\/\/doi.org\/10.1111\/bph.13692","archive":["Portico"],"relation":{},"ISSN":["0007-1188"],"issn-type":[{"value":"0007-1188","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1,26]]}}}